UH GENEVA MEDICAL CENTER — History
CCN 361307 | 3-year financial timeline | COVID resilience: 64/100
🛡️ Public data only — no PHI permitted on this instance.
$62M
Latest Revenue (FY2022)
+10.8%
Revenue CAGR (3yr)
11.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $50M | $57M | $62M | +8.7% | +10.8% |
| Operating Expenses | $44M | $48M | $55M | +12.9% | +11.1% |
| Operating Margin | 11.5% | 14.3% | 11.0% | -23.1% | -2.1% |
| Net Income | $6M | $8M | $7M | -16.4% | +8.5% |
| Licensed Beds | 25 | 25 | 25 | +0.0% | +0.0% |
| Total Patient Days | 5,756 | 6,832 | 5,978 | -12.5% | +1.9% |
| Medicare Day % | 47% | 39% | 41% | +4.9% | -6.7% |
| Medicaid Day % | 3% | 2% | 3% | +44.6% | -3.1% |
COVID Impact & Recovery
Resilience Score: 64/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +22.8% ($50M → $62M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+10.8%
This Hospital
+7.6%
State Avg
Latest Margin
11.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $67M | 10.8% |
| FY2024 (proj) | $73M | 10.5% |
| FY2025 (proj) | $79M | 10.3% |